NIH is the MVP of Biomedical Research: Why Getting Them More Resources the Right Way Matters
This article was originally published in RPM Report
Executive Summary
Sen. Warren is making headlines for proposing a “swear jar” to fund NIH with payments from drug manufacturers who settle fraud cases. That idea is based on faulty facts and worse logic – and is counterproductive for the goal of increasing spending on biomedical research.